PharmaTimes

JANUARY 10, 2024

The partnership will advance VTP-500 from early development to phase 2 clinical trials

93

93

Pharma Marketing Network

JUNE 12, 2020

Just like coronavirus, other diseases have a higher incidence in some locations than others – for example diabetes is far more prevalent in Alabama than it is Colorado. The post What Pharmaceutical Marketers Can Learn from the Coronavirus Response appeared first on Pharma Marketing Network. One-size-fits-all just doesn’t work.

Marketing 75

Marketing Pharmaceutical Doctors Sales 75

Pharmaceutical Technology

APRIL 15, 2024

Discover ImmunityBio Inc's groundbreaking patent for a cross-reactive SARS-CoV2 vaccine targeting multiple variants. Learn how this innovative method boosts immune response and memory cells for enhanced protection.

59

59

The Brooks Group

MARCH 23, 2020

A whopping 73 percent of respondents indicated that they are significantly (30 percent) or slightly (43 percent) behind on plan as a result of Coronavirus. Sales leaders are responding to the Coronavirus by taking action to mitigate the impact. Organizations Are Taking Measures to Mitigate Impact.

Sales 63

Sales Training Prospecting Leads 63

Fierce Pharma

AUGUST 15, 2023

As the coronavirus surged and subsided, several biopharma companies experienced exaggerated revenue spikes and troughs. Thanks to sales of their metabolism drugs, Novo Nordisk and Eli Lilly posted the biopharma industry’s largest revenue gains in the second quarter—by far.

Biopharma 246

Biopharma Sales Pharma 246

Fierce Pharma

JUNE 16, 2023

That was the message Thursday from an FDA advisory committee, which decided unanimously that COVID vaccines this fall should not provide coverage against the original, wild-type coronavirus and that protection only is needed against an XBB strain.

FDA 256

FDA 256

Medgadget

JULY 20, 2022

Researchers at the California Institute of Technology, better known as Caltech, have developed a nanoparticle vaccine that appears to confer broad protection against SARS-like betacoronaviruses. This includes SARS-CoV-2, responsible for the current pandemic, and SARS-CoV, which caused the original SARS pandemic in the early 2000s.

Medicine 90

Medicine 90

PharmaVoice

JANUARY 22, 2024

A new study shows that a universal vaccine would lead to huge financial and mortality wins during a pandemic, but development has been slow going.

Leads 52

Leads 52

Fierce Pharma

AUGUST 16, 2023

With plasma collection as its stock-in-trade, the struggles of | With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a surge in post-pandemic collections—and an $11.7B acquisition of Swiss blood specialist Vifor—has rekindled the growth of Australia’s largest biotech.

242

242

Pharmacy Times

JANUARY 18, 2024

The researchers found that the genomic material was extremely sensitive to the degradation.

65

65

Pharmaceutical Technology

JULY 7, 2023

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) is under clinical development by Blue Sky Immunotherapies and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN).

40

40

Pharmaceutical Technology

JULY 7, 2023

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) is under clinical development by Blue Sky Immunotherapies and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN).

40

40

MedCity News

APRIL 5, 2023

But Pardes Bioscience’s coronavirus journey is ending following the Phase 2 failure of an antiviral that was expected to compete with Pfizer’s Paxlovid. The FDA granted emergency use authorization to an InflaRx antibody drug that treats hospitalized Covid-19 patients.

FDA 109

FDA Patients Biopharma Pharma 109

pharmaphorum

DECEMBER 20, 2023

The validity of the patent is at the heart of patent litigation between CureVac and fellow German biotech BioNTech and its partner Pfizer, claiming infringement by their Comirnaty coronavirus shot.

107

107

Pharmaceutical Technology

APRIL 11, 2023

The White House coronavirus coordinator Ashish Jha said: “It’s been very clear to us that the market on this is moving very slowly. The investment will come from funds allocated for coronavirus testing and other priorities. The White House directed HHS to allocate $5bn to fund the development efforts.

Government 105

Government Marketing Patients 105

pharmaphorum

OCTOBER 4, 2023

variant of the coronavirus. Novavax has been given the go-ahead by regulators in the US for an updated version of its COVID-19 vaccine that targets the XBB.1.5 The FDA has signed off on the new protein-based shot, which joins two XBB.1.5-directed

FDA 93

FDA 93

MedCity News

AUGUST 7, 2022

The increases in enrollment are likely because of changes in the economy, policy changes like Medicaid expansion in the Affordable Care Act and the temporary continuous enrollment requirement from the Family First Coronavirus Response Act, the report said. .

Insurance 120

Insurance 120

David Bagga

FEBRUARY 22, 2022

I know it’s pretty much you know, it’s pretty crazy what’s going on right now with a coronavirus. I hope everyone is finishing the word strong first and foremost, I hope everyone is staying safe out there. And […]. The post Start Preparing Yourselves For More Video Interviews B/C Of Corona Virus appeared first on.

130

130

PharmaTimes

JUNE 6, 2023

Rocketvax and Basel University therapy uses a modified coronavirus that activates an immune response - News - PharmaTimes

91

91

PharmaTimes

AUGUST 8, 2023

Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response - News - PharmaTimes

79

79

MedCity News

AUGUST 26, 2022

The company notes that its patented work in respiratory infectious disease began years before the start of the Covid-19 pandemic, when the biotech was pursuing an mRNA vaccine for a different coronavirus.

Biopharma 113

Biopharma Pharma 113

World of DTC Marketing

NOVEMBER 1, 2020

THE SKINNY : President Trump’s repeated assertions the United States is “rounding the turn” on the novel coronavirus are proving to be untrue as new cases surge in Midwest states. Fauci, a leading member of the government’s coronavirus response, said the United States needed to make an “abrupt change” in public health practices and behaviors.

Healthcare 188

Healthcare Healthcare Food and Drug Administration Distribution 188

Pharmaceutical Technology

JUNE 6, 2023

Our pan-coronavirus vaccine candidate presents a potential universal solution to the evolving nature of SARS-CoV-2 and potentially future coronaviruses by targeting mucosal immunity at the source, being readily deployable through faster manufacturing and exhibiting lower barriers for storage and transportation.”

Transportation 92

Transportation Manufacturing Leads 92

World of DTC Marketing

DECEMBER 22, 2021

The coronavirus has diminished trust in the U.S. Found roughly 1 in 4 adults experiencing a heart attack or stroke would rather stay at home than risk getting infected with the coronavirus at the hospital. Many patients are shunning hospitals and clinics. A Harris poll on behalf of the American Heart Assn.

Patients 241

Patients Doctors Healthcare Healthcare 241

pharmaphorum

MARCH 18, 2020

Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.

Pharma 52

Pharma Government Medicine Healthcare 52

World of DTC Marketing

AUGUST 2, 2020

QUICK READ : Obesity is associated with a higher risk of developing severe symptoms and complications of coronavirus disease, independent of other illnesses, such as cardiovascular disease. Data seems to suggest that people with obesity are more likely to become severely ill due to COVID-19, the disease caused by the novel coronavirus.

Insurance 295

Insurance Doctors Physicians Healthcare 295

MedCity News

AUGUST 31, 2022

The FDA has authorized mRNA Covid-19 booster shots designed to protect against the original strain of the novel coronavirus, as well as the two omicron subvariants that are currently driving U.S. An advisory committee to the CDC is scheduled to discuss these vaccines and vote on their recommended use on Thursday.

FDA 98

FDA Biopharma Pharma 98

World of DTC Marketing

APRIL 15, 2021

A recent Pew Research Center poll reports that 39 percent of people say they definitely or probably wouldn’t get a coronavirus vaccination. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness. A Tiny Number of People Will Be Hospitalized Despite Being Vaccinated.

Food and Drug Administration 203

Food and Drug Administration Government Safety Side effects 203

Pharmaceutical Technology

JUNE 23, 2023

IRBM has extended its collaboration with MSD to develop peptide therapeutics, following results in coronavirus, cholesterol, and obesity.

59

59

PharmaTimes

JUNE 24, 2022

efficacy in participants previously infected with coronavirus COVID-19 Beta-containing vaccine provides 75.1%

91

91

World of DTC Marketing

AUGUST 21, 2020

More than 107 million American adults are obese, and their ability to return safely to work, care for their families and resume daily life could be curtailed if the coronavirus vaccine delivers weak immunity for them. In the United States, where at least 4.6

Insurance 238

Insurance Physicians Healthcare Healthcare 238

PharmaVoice

APRIL 17, 2023

With a $5 billion dollar infusion, a new White House program is helping catalyze development of next-gen treatments, from pan-coronavirus vaccines to enhanced antivirals.

52

52

World of DTC Marketing

FEBRUARY 24, 2021

SUMMARY: In a recent study by The Harris Poll on behalf of TIME, the overwhelming majority of Americans (78%) admitted to delaying routine medical services and health care appointments due to the coronavirus pandemic. Via The NY Times “the coronavirus pandemic has yet to end, but we are already beginning to feel the aftershocks.

Healthcare 200

Healthcare Healthcare Insurance Medical 200

World of DTC Marketing

APRIL 11, 2021

Based on the virus a number of vaccines targeting the spike protein were designed, tested in animal models and found to be quite promising against SARS and other coronavirus illnesses like Middle East respiratory syndrome. QUICK THOUGHT: People believe the COVID-19 vaccine was developed in less than a year but that’s not true.

Pharmaceutical 303

Pharmaceutical Patients Sales 303

World of DTC Marketing

MARCH 21, 2021

pharmaceutical firms behind the approved coronavirus vaccines — Johnson & Johnson, Moderna, and Pfizer — have quietly touted plans to raise prices on coronavirus vaccines in the near future and to capitalize on the virus’s lasting presence. What about countries and people that can’t afford those prices?

Patients 201

Patients Pharma Healthcare Healthcare 201

Pharmacy Times

MAY 19, 2023

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

55

55

World of DTC Marketing

JULY 28, 2020

that has never brought a product to market, announced in late January that it was working on a coronavirus vaccine. According to The NY Times “On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S.

Government 181

Government Pharma Marketing 181